Dr. Wang Jian

Chairman and Co-Founder of BGI Group; Professor; Academician-level Researcher

Co-founded BGI (formerly Beijing Genomics Institute), which has grown into one of the world's largest genomics organizations; played a pivotal role in China's contribution to the Human Genome Project and subsequent large-scale sequencing initiatives including the 1000 Genomes Project; led the development and global deployment of NIPT (noninvasive prenatal testing) technology through BGI, which has been used to screen millions of pregnancies worldwide for chromosomal aneuploidies such as Down syndrome; drove the creation of high-throughput sequencing platforms that have dramatically reduced the cost of whole genome sequencing; published in Nature, Science, Nature Genetics, and The New England Journal of Medicine

Dr. Wang's primary role is in genomics research leadership and technology development rather than direct clinical consultations. However, BGI Genomics offers clinical genetic testing services including NIPT, whole exome sequencing, and carrier screening panels through its network of clinical laboratories. Patients can access BGI testing services through referral from their treating physician or through BGI's clinical service centers in Shenzhen and other major Chinese cities.

Research this doctor's background on trusted platforms.

Results are automated searches and may include other individuals with similar names.